Sunday, November 16, 2025

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Emerita Resources Hits 2.7% Copper, 1.85 g/t Gold Over 9.6 Metres At El Cura

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

Related News

Chainsaw To Scalpel: Trump’s Cabinet Clamps Down on Musk’s Government Makeover

In the latest episode of this stranger-than-fiction reality show called US government, President Donald Trump...

Tuesday, March 11, 2025, 03:47:00 PM

Trump Administration Tied to Tate Brothers’ Release from Romanian Custody

It pays to be in Trump's manosphere...
Friday, February 28, 2025, 07:28:00 AM

Could DWAC’s Success Lead Trump To Invest In Other SPACs?

The President Trump SPAC, Digital World Acquisition Corp. (NASDAQ: DWAC), has been by far the...

Saturday, October 23, 2021, 09:00:00 AM

Trump Administration Rolls Back Tariffs on Products US Can’t Produce

The Trump administration is rolling back tariffs on products that cannot be domestically produced, a...

Monday, October 20, 2025, 10:44:00 AM

Maine Becomes The Second State To Ban Donald Trump From 2024 Presidential Race

Maine’s Democratic Secretary of State, Shenna Bellows, made a historic decision on Thursday, removing former...

Thursday, December 28, 2023, 07:48:45 PM